Lotus Eye Hospital
107.18
+3.65(+3.53%)
Market Cap₹222.90 Cr
PE Ratio339.68
Company Performance:
1D+3.53%
1M-5.22%
6M-11.28%
1Y+87.84%
5Y+132.49%
View Company Insightsright
More news about Lotus Eye Hospital
06Feb 26
Vramath Financial Services Acquires 10.02% Stake in Lotus Eye Hospital and Institute Limited
Vramath Financial Services Private Limited acquired 20,84,835 equity shares (10.02%) in Lotus Eye Hospital and Institute Limited through open market transactions on February 02, 2025. The acquisition increased their total holding from 1.73% to 10.03%, triggering disclosure requirements under SEBI regulations. The transaction was completed along with persons acting in concert and filed under Regulation 29(1) of SEBI takeover regulations.
 no imag found
30Jan 26
Lotus Eye Hospital And Institute Limited Schedules Board Meeting for February 11, 2026 to Review Q3FY26 Financial Results
Lotus Eye Hospital And Institute Limited has scheduled a board meeting for February 11, 2026, to consider Q3FY26 unaudited standalone financial results for the quarter and year ended December 31st, 2025. The company has notified BSE and NSE in compliance with SEBI regulations. Trading window restrictions are in place and will reopen from February 13, 2026.
 no imag found
27Jan 26
Lotus Eye Hospital Promoter Sangeetha Sundaramoorthy Discloses Share Acquisition Under SEBI Takeover Regulations
Sangeetha Sundaramoorthy has disclosed the acquisition of 14,28,571 shares in Lotus Eye Hospital and Institute Limited from fellow promoter Kavetha Sundaramoorthy at Rs 70 per share, totaling Rs 9,99,99,970. The inter-se transfer, scheduled for February 3, 2026, will increase Sangeetha's stake from 28.1391% to 35.0084% while reducing Kavetha's holding to 2.7456%. The transaction complies with SEBI Takeover Regulations and is priced below the 60-day volume weighted average market price of Rs 81.30.
 no imag found
19Jan 26
Lotus Eye Hospital Announces Postal Ballot Results with Overwhelming Approval
Lotus Eye Hospital And Institute Limited announced successful completion of its postal ballot process with all three director appointments receiving 99.07% shareholder approval. The e-voting conducted through CDSL platform saw 38 members casting 79,25,006 votes, with Dr S Natesan's reappointment as Independent Director for a second five-year term and Dr KS Ramalingam's continuation and fresh appointment as Non-Executive Director all receiving overwhelming support, demonstrating strong shareholder confidence in the board composition.
 no imag found
08Dec 25
Lotus Eye Hospital Fined Rs 5.9 Lakh for Regulatory Non-Compliance
Lotus Eye Hospital and Institute Limited has been fined Rs 2.95 lakh each by BSE and NSE for non-compliance with SEBI's Regulation 17(1A) on board composition. The total penalty amounts to Rs 5.90 lakh. The company states there is no material impact on its financial operations.
 no imag found
02Dec 25
HDFC Bank Announces Allotment of Equity Shares Under ESOS
Lotus Eye Hospital has allotted 677,681 new equity shares under its Employee Stock Option Scheme (ESOS) on April 24, 2023. The shares have a face value of ₹1.00 each. This allotment has increased the bank's paid-up share capital from 5,567,726,428 to 5,568,404,109 equity shares. The ESOS is part of the bank's strategy to align employee interests with shareholders and retain top talent.
 no imag found
23Sept 25
Lotus Eye Hospital Reports Revenue Growth and Expansion at 28th AGM
Lotus Eye Hospital and Institute Limited held its 28th Annual General Meeting, reporting a slight revenue increase from Rs 48.21 crores to Rs 49.56 crores, with a net profit of Rs 73.93 lakhs. The company opened its 9th center in Karur and invested Rs 5.57 crores in capital assets. Despite facing increased operational costs, the company maintains a positive outlook. Key resolutions included re-appointing Dr. Kavetha Sundaramoorthy as director and approving remuneration for Non-Independent Non-Executive Director KS Ramalingam. Lotus Eye Hospital reaffirmed its commitment to providing affordable eye care services.
 no imag found
13Aug 25
Rane Holdings Reports Robust Q1 Growth with 61% Surge in Revenue
Rane Holdings Limited announced robust Q1 financial results. Total income increased by 60.70% to Rs 1,34,554.00 lakhs. Net profit after tax nearly tripled to Rs 5,749.00 lakhs, a 194.80% year-over-year growth. Earnings per share rose significantly from Rs 9.19 to Rs 35.57, marking a 287.00% increase.
 no imag found
Lotus Eye Hospital
107.18
+3.65
(+3.53%)
1 Year Returns:+87.84%
Industry Peers